Short Interest in Rafael Holdings, Inc. (NYSE:RFL) Expands By 43.5%

Rafael Holdings, Inc. (NYSE:RFL) was the target of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 55,181 shares, a growth of 43.5% from the February 12th total of 38,452 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average trading volume of 54,408 shares, the days-to-cover ratio is presently 1.0 days. Based on an average trading volume of 54,408 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.2% of the shares of the company are short sold.

Rafael Price Performance

Shares of RFL stock traded down $0.16 during trading hours on Friday, reaching $1.31. 166,045 shares of the company traded hands, compared to its average volume of 97,912. The firm has a 50-day moving average price of $1.28 and a 200 day moving average price of $1.31. The company has a market cap of $67.56 million, a P/E ratio of -1.54 and a beta of 0.58. Rafael has a 12-month low of $1.12 and a 12-month high of $3.19.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Rafael in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, Rafael currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On Rafael

A number of hedge funds have recently modified their holdings of RFL. Simplex Trading LLC purchased a new position in shares of Rafael during the second quarter valued at about $32,000. Marshall Wace LLP bought a new position in shares of Rafael during the 2nd quarter valued at approximately $50,000. Citadel Advisors LLC raised its stake in shares of Rafael by 132.3% in the third quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock valued at $99,000 after acquiring an additional 41,335 shares during the period. Cable Car Capital LP purchased a new stake in Rafael in the 2nd quarter worth about $173,000. Finally, Geode Capital Management LLC raised its holdings in shares of Rafael by 25.4% in the fourth quarter. Geode Capital Management LLC now owns 445,866 shares of the company’s stock worth $526,000 after buying an additional 90,417 shares during the period. 11.30% of the stock is currently owned by institutional investors.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.